ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging.
Yuxin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.